Eagle Wealth Strategies »

Vertex Pharmaceuticals Incorporated shares owned by Eagle Wealth Strategies

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Eagle Wealth Strategies from 13F filings

Historical chart of Eagle Wealth Strategies investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Eagle Wealth Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Eagle Wealth Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $405k 964 420.48
2023-12-31 $415k 1.0k 406.89

More positions owned by Eagle Wealth Strategies

Vanguard Index Fds S&p 500 Etf Shs (VOO)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Accenture Plc Ireland Shs Class A (ACN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Arthur J. Gallagher & Co. (AJG)
Apple (AAPL)
Chevron Corporation (CVX)
JPMorgan Chase & Co. (JPM)
Advanced Micro Devices (AMD)
Fulton Financial (FULT)
Amazon (AMZN)

View all positions for Eagle Wealth Strategies

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated